The European Medicines Agency warns that young children given GlaxoSmithKline's swine flu shot may get a fever after their second dose.

    In a statement issued Friday, the European drug regulator said data from GlaxoSmithKline PLC showed a higher number of children aged six months to 3 years had a fever after their second dose of the Pandemrix vaccine, compared with the first. Kids were also more likely to have side effects like muscle pain, drowsiness, and irritability.

    The European regulator recommends children get two doses of swine flu vaccine, though Glaxo says one dose is enough.

    Glaxo's vaccine contains an adjuvant, a chemical compound to boost the immune response. It is sold across Europe and Canada.

    Another formulation of Glaxo's vaccine, without the adjuvant, is available in the U.S. Vaccines with adjuvants usually cause more side effects. No flu vaccines with adjuvants are licensed in the U.S.

    Last month, Glaxo advised health authorities not to use one batch of its Canadian-manufactured swine flu vaccine in case it triggered life-threatening side effects like anaphylactic shock.

    In a press briefing on Thursday, the World Health Organization's flu chief Keiji Fukuda said that more than 150 million doses of swine flu vaccine have been distributed in more than 40 countries and that they had not seen any evidence to suggest the vaccines caused worrying side effects.

    歐洲藥品管理局發出警告說
，注射過葛蘭素史克公司的豬流感疫苗的幼兒，二次注射之後可能會發熱。

    在星期五發布的一項聲明中，歐洲醫藥管理部門說，來自葛蘭素史克公司的數據表明，與第一次注射相比，數量較多的年齡在6個月到3歲的兒童第二次注射 Pandemnrix 疫苗之後
，已出現發熱現象。很可能出現副作用
，如肌肉酸痛、困倦和過敏。

    盡管葛蘭素史克公司稱注射一次豬流感疫苗就足夠了，但歐洲藥品管理部門仍建議兒童注射兩次。

    葛蘭素史克公司的疫苗含有一種促進免疫反應的輔藥和化學物質。這種疫苗在全歐洲和加拿大銷售。

    葛ge蘭lan素su史shi克ke公gong司si另ling一yi種zhong配pei方fang的de疫yi苗miao不bu含han輔fu助zhu藥yao料liao，在zai美mei國guo可ke以yi買mai到dao。含han有you輔fu助zhu藥yao料liao的de疫yi苗miao通tong常chang引yin起qi更geng多duo的de副fu作zuo用yong。這zhe種zhong疫yi苗miao在zai美mei國guo沒mei有you獲huo得de許xu可ke。

    上個月，葛蘭史克公司建議衛生機構
，如果加拿大生產的一批疫引發威脅生命的象過敏性休克這樣的副作用，則不要使用。

    在星期二的新聞發布會上
，世界衛生組織流感部幹事福田敬二說，1.5億支流感疫苗已發放到40多個國家，還說，他們並沒有發現任何表示疫苗引起的讓人擔憂的副作用的證據。